Michal Mikula

35PUBLICATIONS
107CO-AUTHORS
Haematological tumoursCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 13, 2026
Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

|Mar 27, 2026
Metabolomic Study of 7-Ethyl-9-(N-methyl)aminomethyl-10-hydroxycamptothecin Derivative (NMe)-The Chemotherapeutic Drug Candidate Versus Irinotecan (IR) on a Mouse Model.

Piotr Surynt, Beata Naumczuk, Magdalena Popławska

|Feb 13, 2026
Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts.

Katarzyna Unrug-Bielawska, Zuzanna Sandowska-Markiewicz, Ewelina Kaniuga

|Jul 30, 2025
The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans.

Maria Kulecka, Paweł Jaworski, Natalia Zeber-Lubecka

|Jul 12, 2025
Comparative Analysis of Gut Microbiota Responses to New SN-38 Derivatives, Irinotecan, and FOLFOX in Mice Bearing Colorectal Cancer Patient-Derived Xenografts.

Katarzyna Unrug-Bielawska, Zuzanna Sandowska-Markiewicz, Magdalena Piątkowska

|Oct 26, 2024
Dysbiosis of the Upper Gastrointestinal Tract in Head-and-Neck Cancer Survivors: A Pilot Study Using the Capsule Sponge Device.

Natalia Zeber-Lubecka, Maria Kulecka, Michalina Dabrowska

Pageof 6

Frequent Collaborators

6 joint publications

Paweł Czarnowski

6 joint publications

Izabela Rumienczyk

5 joint publications

Jerzy Ostrowski

5 joint publications

Filip Ambrozkiewicz